황금성공략법 ㈗ 바다이야기환전가능 ㈗
페이지 정보
작성자 영규용남 작성일25-08-12 05:46 조회33회 댓글0건관련링크
-
http://90.ruk737.top
22회 연결
-
http://99.ruk999.top
22회 연결
본문
바다이야기예시종료 ㈗ 슬롯머신 확률 ㈗◑ 91.rtb667.top ㎒[Shin-Min Joon, Edaily Reporter] Humedix of Huons Group strengthened its aesthetics portfolio by securing commercialization rights for Reedle Booster in Korea.
Humedix has signed an exclusive sales agreement for ‘Reedle Booster’ with Evov Therapeutics on August 8. From the left, Humedix CEO Kang Min-jong and Evov Therapeutics CEO Park Byung kook pose 상환조건 for a photo during a signing ceremony for an exclusive sales agreement. (image=Humedix)
Humedix Co. Ltd. announced on August 11 that it has signed an exclu 정기적금 계산기 sive commercialization agreement for Reedle Booster with Evov Therapeutics Co. Ltd.
The Reedle Booster co developed by VT Cosmetics (hereafter VT) and Evov Therapeutics, is an exc 정부창업자금 lusive product made for use in hospitals and clinics, leveraging the popularity of VT’s Reedle Shot in the global aesthetics market. Compared to injectable skin booster treatments, Reedle Booster proc 토마토저축은행 edure offers minimal pain and a shorter recovery time, allowing for a faster return to daily life after the treatment. It also provides immediate improvement in skin vitality.
With VT’s prop 전세대출문의 rietary RED REEDLE™ channeling technology Reedle Booster creates micro-channels on the skin surface, facilitating delivery of active ingredients deep into the dermal layer.
Through this agreement Humedix has secured the exclusive commercialization rights in Korea for Reedle Booster EX and Reedle Booster PN, which contain next generation plant derived exosomes and small molecule polynucleotides (PN) as their respective active ingredients. Humedix plans to expand its presence in the aesthetics market by focusing on distribution to hospitals and clinics specializing in aesthetics including dermatology and plastic surgery.
Evov Therapeutics CEO Park Byung kook said “Through our partnership with Humedix which has established a strong foothold in aesthetics market in Korea Evov Therapeutics plans to promote the technological prowess of Reedle Booster and maximize its brand value.”
Humedix CEO Kang Min jong said “Reedle Booster is a professional product that started from the brand awareness and consumer needs of the Reedle Shot that has already achieved great success in K-beauty market. We have strengthened our product portfolio with new additions such as this treatment solution targeting the epidermis layer differentiated from our existing product line.”
신민준 (adonis@edaily.co.kr)
Humedix has signed an exclusive sales agreement for ‘Reedle Booster’ with Evov Therapeutics on August 8. From the left, Humedix CEO Kang Min-jong and Evov Therapeutics CEO Park Byung kook pose 상환조건 for a photo during a signing ceremony for an exclusive sales agreement. (image=Humedix)
Humedix Co. Ltd. announced on August 11 that it has signed an exclu 정기적금 계산기 sive commercialization agreement for Reedle Booster with Evov Therapeutics Co. Ltd.
The Reedle Booster co developed by VT Cosmetics (hereafter VT) and Evov Therapeutics, is an exc 정부창업자금 lusive product made for use in hospitals and clinics, leveraging the popularity of VT’s Reedle Shot in the global aesthetics market. Compared to injectable skin booster treatments, Reedle Booster proc 토마토저축은행 edure offers minimal pain and a shorter recovery time, allowing for a faster return to daily life after the treatment. It also provides immediate improvement in skin vitality.
With VT’s prop 전세대출문의 rietary RED REEDLE™ channeling technology Reedle Booster creates micro-channels on the skin surface, facilitating delivery of active ingredients deep into the dermal layer.
Through this agreement Humedix has secured the exclusive commercialization rights in Korea for Reedle Booster EX and Reedle Booster PN, which contain next generation plant derived exosomes and small molecule polynucleotides (PN) as their respective active ingredients. Humedix plans to expand its presence in the aesthetics market by focusing on distribution to hospitals and clinics specializing in aesthetics including dermatology and plastic surgery.
Evov Therapeutics CEO Park Byung kook said “Through our partnership with Humedix which has established a strong foothold in aesthetics market in Korea Evov Therapeutics plans to promote the technological prowess of Reedle Booster and maximize its brand value.”
Humedix CEO Kang Min jong said “Reedle Booster is a professional product that started from the brand awareness and consumer needs of the Reedle Shot that has already achieved great success in K-beauty market. We have strengthened our product portfolio with new additions such as this treatment solution targeting the epidermis layer differentiated from our existing product line.”
신민준 (adonis@edaily.co.kr)
댓글목록
등록된 댓글이 없습니다.